HEAR FROM PEERS

Peer-to-peer learning hub

Play Video

Novel Genomic Testing: Improving Diagnostic Confidence for Lung Nodules

Hear how Dr. Kurman uses Percepta GSC to stratify the risk of primary lung cancer across all pre-test risk groups to guide patient management when bronchoscopy is inconclusive

Case Studies & Presentations

Percepta GSC resource library

Watch case studies and testimonials from physicians or on-demand videos about Percepta GSC and its clinical utility.

Video Thumbnail
Envisia_Video-Play-Button

Percepta GSC and Envisia Classifier 
Case Study

Dr. Nina Maouelainin shares a case where Percepta GSC up-classified the risk of lung cancer guiding the next intervention step, and Envisia determined a UIP pattern to improve ILD diagnostic confidence, guiding management using a non-invasive bronchoscopy.
Video Thumbnail
Envisia_Video-Play-Button

Percepta GSC Up-Classification Case Study

Dr. Andres Yepes shares a clinical case where Percepta GSC up-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, informing the next intervention steps.
Video Thumbnail
Envisia_Video-Play-Button

Percepta GSC Down-Classification 
Case Study

Dr. Andres Yepes shares a case where Percepta GSC down-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, saving the patient from an unnecessary invasive procedure.
Video Thumbnail
Envisia_Video-Play-Button

Percepta GSC Physician Testimonial

Hear from Dr. Nina Maouelainin on how she integrated Percepta GSC into her clinical practice and the test’s impact on patient management.
Preview thumbnail for publication
Envisia_Video-Play-Button

Percepta GSC Clinical Case Review​

Dr. Krish Bhadra shares a case where Percepta GSC down-classified the risk and changed patient management.

Stratify the risk of primary lung cancer to guide patient management

Inconclusive bronchoscopy results can lead to uncertainty in next steps and delays in diagnosis. Percepta GSC stratifies the risk of primary lung cancer to guide patient management when bronchoscopy is inconclusive.